Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Impact in
- Immunology 505
Classified as
- Journal
- Nature Medicine
In The Last Decade
doi.org/10.1038/nm1589 →Countries where authors are citing Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
This map shows the geographic impact of Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists more than expected).
Fields of papers citing Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
This network shows the impact of Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.
About Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
This paper, published in 2007, received 722 indexed citations . Written by Holger Kanzler, Franck J. Barrat, Edith M. Hessel and Robert L. Coffman covering the research area of Immunology and Epidemiology. It is primarily cited by scholars working on Immunology (505 citations), Molecular Biology (125 citations), Epidemiology (122 citations), Microbiology (78 citations) and Oncology (71 citations). Published in Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1038/nm1589.